Gilead Goes Full Steam Ahead In Oncology With Big Lung Cancer Push
Islatravir/Lenacapavir Program Under Way Again
The company has eight lung cancer trials running and plans for nine by the end of the year, including five with Trodelvy alone. Gilead is also looking ahead to an FDA verdict on lenacapavir.
